To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open1,133
High1,133
Low1,065.9
Prev. Close1,118.95
Avg. Traded Price1,101.31
Volume9,303

MARKET DEPTH

info2
Total bid5,637.00
Total ask7,772.00
OrdersQtyBid
151098.05
110001098
1101097
11301096
111093
AskQtyOrders
110211
110511
1107.822
1107.8523
1108333

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1,065.90an hour ago
1,133.003 hours ago
arrow

LOWER/UPPER CIRCUITS

895.20
1,342.70
arrow
Fredun Pharmaceuticals Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 30.71%, in the last year to ₹456.27 Cr. Its sector's average revenue growth for the last fiscal year was 10.79%.
noteAnnual Net Profit,rose 33.18% in the last year to ₹20.81 Cr. Its sector's average net profit growth for the last fiscal year was 38.8%.
notePrice to Earning Ratio,is 22.54, lower than its sector PE ratio of 42.26.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 11.14%
Net profit growth 5Y CAGR : 28.5%
Fredun Pharmaceuticals Limited is engaged in manufacturing of pharmaceutical products. The company is trusted by customers across Africa, Southeast Asia, Commonwealth of Independent States (CIS) countries and Latin America. The company has diversified into manufacturing of dietary/herbal supplements, nutraceuticals and other healthcare products along with animal healthcare products. With such a diverse range of products, the company’s objective is to be a holistic healthcare provider.
personal

Grow your wealth with more research recommendations

+91